TY - JOUR
T1 - The role of K ATP channels on ischemia-reperfusion injury in the rat testis
AU - Tsounapi, Panagiota
AU - Saito, Motoaki
AU - Dimitriadis, Fotios
AU - Kitatani, Kazuyuki
AU - Kinoshita, Yukako
AU - Shomori, Kohei
AU - Takenaka, Atsushi
AU - Satoh, Keisuke
PY - 2012/5/15
Y1 - 2012/5/15
N2 - Aims: To investigate the participation of K ATP channels on the ischemia-reperfusion (IR)-induced apoptosis in the rat testis. Main methods: Eight-week-old male Sprague-Dawley rats were divided into three groups: control and IR rats without or with cromakalim (300 μg/kg intraperitoneally), 30 min before the induction of ischemia. The right testicular artery and vein were clamped to induce ischemia in the testis. Sixty minutes after the ischemia, a 24 h period of reperfusion followed. Then, expressions of K IR6.1, K IR6.2, caspase-3, PARP, Fas, FasL, and K IR6.1 and K IR6.2 mRNAs were investigated by Western blot analyses and real-time PCR methods, respectively. Furthermore, testicular tissues were processed for histological evaluation and TUNEL staining. Key findings: Expressions of K IR6.1 protein and mRNA were more than 10-fold of those of K IR6.2 protein and mRNA in the testis. IR significantly increased the expressions of K IR6.1 protein and mRNA as well as K IR6.2 mRNA, caspase-3, and TUNEL index in the testis compared to the control. PARP expressions were significantly lower in the IR group than those of the control. Histologically, severe acute germ cell damage was observed in the IR testis. Treatment with cromakalim ameliorated these parameters compared to the non-treated IR group. There were no significant differences on Fas, FasL and protein level of K IR6.2 expressions between any of the groups. Significance: Treatment with cromakalim has a protective effect against IR-induced testicular damage via activating K ATP channels. This is the first study to give evidence for the advantageous effect of cromakalim in the germ cell-specific apoptosis induced by testicular IR.
AB - Aims: To investigate the participation of K ATP channels on the ischemia-reperfusion (IR)-induced apoptosis in the rat testis. Main methods: Eight-week-old male Sprague-Dawley rats were divided into three groups: control and IR rats without or with cromakalim (300 μg/kg intraperitoneally), 30 min before the induction of ischemia. The right testicular artery and vein were clamped to induce ischemia in the testis. Sixty minutes after the ischemia, a 24 h period of reperfusion followed. Then, expressions of K IR6.1, K IR6.2, caspase-3, PARP, Fas, FasL, and K IR6.1 and K IR6.2 mRNAs were investigated by Western blot analyses and real-time PCR methods, respectively. Furthermore, testicular tissues were processed for histological evaluation and TUNEL staining. Key findings: Expressions of K IR6.1 protein and mRNA were more than 10-fold of those of K IR6.2 protein and mRNA in the testis. IR significantly increased the expressions of K IR6.1 protein and mRNA as well as K IR6.2 mRNA, caspase-3, and TUNEL index in the testis compared to the control. PARP expressions were significantly lower in the IR group than those of the control. Histologically, severe acute germ cell damage was observed in the IR testis. Treatment with cromakalim ameliorated these parameters compared to the non-treated IR group. There were no significant differences on Fas, FasL and protein level of K IR6.2 expressions between any of the groups. Significance: Treatment with cromakalim has a protective effect against IR-induced testicular damage via activating K ATP channels. This is the first study to give evidence for the advantageous effect of cromakalim in the germ cell-specific apoptosis induced by testicular IR.
KW - Apoptosis
KW - Caspase-3
KW - Ischemia-reperfusion injury
KW - KATP channels
KW - Testis
UR - http://www.scopus.com/inward/record.url?scp=84860473728&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84860473728&partnerID=8YFLogxK
U2 - 10.1016/j.lfs.2012.03.006
DO - 10.1016/j.lfs.2012.03.006
M3 - Article
C2 - 22480512
AN - SCOPUS:84860473728
SN - 0024-3205
VL - 90
SP - 649
EP - 656
JO - Life Sciences
JF - Life Sciences
IS - 17-18
ER -